+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID01218776

International Study of Acute Coronary Syndromes Tracking Patient Outcomes and Treatments

Led by University of Bologna · Updated on 2025-04-16

36000

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What this Trial Is About

Researchers are conducting the International Survey of Acute Coronary Syndromes ISACS, an observational study designed to collect and analyze data from patients with acute coronary syndromes such as STEMI or NSTEMI. The study aims to document patient characteristics, in-hospital outcomes, and longer-term results at 6 months and 1 year. It also assesses invasive procedures, complications, and how well treatments follow established guidelines internationally. This study is non-interventional and serves as a patient registry. It collects detailed information from participating centers on treatment regimens and procedures without administering any specific therapies. The study covers both retrospective and prospective data gathering, focusing on outcomes and adherence to recommended care practices across multiple countries. Participants provide data through hospital records and follow-up evaluations at 30 days, 6 months, and 1 year. Researchers measure outcomes including all-cause mortality, cardiovascular deaths, recurrent heart attacks, and genetic studies related to clinical results. Adherence to guideline-recommended therapies is also monitored. The study is led by the University of Bologna and involves various international collaborators, with patient participation lasting up to one year after initial admission.

CONDITIONS

Brief Title

International Survey of Acute Coronary Syndromes

Research Team

R

Raffaele Bugiardini, MD

L

Lina Badimon, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here